Infinity Pharmaceuticals
Eva Huang has extensive experience in executive search and consulting, holding significant leadership roles since 2001. Currently, Eva serves as Team Lead at IPICHINA since 2007 and as Team Leader at IPI China, also since 2001. Prior to these positions, Eva worked as a Senior Consultant at Talentpower from 2002 to 2005.
This person is not in any teams
This person is not in any offices
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.